Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

VDK NaturaSyn

Request full access

A newly created high-tech enterprise specializing in the research and development, production and sales of biological health products

ChinaFounded 2021Biotech & Life Sciences

About VDK NaturaSyn

VDK NaturaSyn operates as a biotechnology company specializing in the biomanufacturing of high-quality, natural ingredients for the global health and wellness market. Emerging in 2021 from BLRH Biotech Co., Ltd., the company leverages synthetic biology to produce ingredients for food, dietary supplements, and Active Pharmaceutical Ingredients (APIs). This approach is positioned as an alternative to traditional plant extraction, aiming to resolve issues related to production rate, quality control, and environmental impact.

The company's core business involves using microbial cell factories and fermentation technology to create functional substances. The process encompasses four main pillars: exploring metabolic pathways and key enzymes, improving enzyme efficiency through evolution and high-throughput screening, reconstructing microorganisms for optimal yield, and scaling up production in cell factories. VDK NaturaSyn has secured $13.9 million in a Series A funding round in August 2023 from investors including Fortune Capital, CMG SDIC Fund, Addor Capital, and CDIB Capital Group. The company is recorded as generating revenue and proceeded with a Series A2 round in April 2025.

VDK NaturaSyn's product portfolio includes 5-hydroxytryptophan (5-HTP), melatonin, resveratrol, β-carotene, and astaxanthin, which are marketed under trademarks like HTPeace™, MelatoPure®, and VDKPure™. These ingredients are used in health foods, dietary supplements, cosmetics, and pet health products. The company operates from a large campus in Baoding, China, with significant investment in its production and R&D facilities, which include enzyme engineering, genetic engineering, and fermentation labs. VDK NaturaSyn holds numerous certifications, including cGMP, HACCP, ISO22000, FSSC2000, Kosher, and Halal, to meet the needs of a diverse user base across North America, Europe, and Asia.

Source: Dealroom company data

At a glance

Status
Operational
Employees
22
Open positions
None listed
Dealroom signal
56.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2024 $14M $55M Huachuang Yida · Addor Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

VDK NaturaSyn website traffic

Latest recorded traffic for VDK NaturaSyn is 450 monthly website visits, up 164.7% over the last three months. VDK NaturaSyn's team grew 22.2% over the past year.

Latest monthly visits450 3-month web change+164.7% 1-year team growth+22.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

VDK NaturaSyn in its local ecosystem

Live from Dealroom

The VDK NaturaSyn office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Huachuang Yida
  • Addor Capital

Other known investors1 additional known investor

  • CDIB Capital Group
Employees 22 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇳 China69.2%
🇦🇺 Australia15.4%
🇭🇰 Hong Kong7.7%
🇺🇸 United States7.7%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about VDK NaturaSyn on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See VDK NaturaSyn’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.